IL98470A0 - Substituted benzimidazoles,process for their preparation and their pharmaceutical use - Google Patents

Substituted benzimidazoles,process for their preparation and their pharmaceutical use

Info

Publication number
IL98470A0
IL98470A0 IL98470A IL9847091A IL98470A0 IL 98470 A0 IL98470 A0 IL 98470A0 IL 98470 A IL98470 A IL 98470A IL 9847091 A IL9847091 A IL 9847091A IL 98470 A0 IL98470 A0 IL 98470A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical use
substituted benzimidazoles
benzimidazoles
substituted
Prior art date
Application number
IL98470A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL98470A0 publication Critical patent/IL98470A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL98470A 1990-06-20 1991-06-12 Substituted benzimidazoles,process for their preparation and their pharmaceutical use IL98470A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
IL98470A0 true IL98470A0 (en) 1992-07-15

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98470A IL98470A0 (en) 1990-06-20 1991-06-12 Substituted benzimidazoles,process for their preparation and their pharmaceutical use

Country Status (27)

Country Link
EP (1) EP0535081A1 (cs)
JP (1) JPH05507713A (cs)
CN (1) CN1058212A (cs)
AP (1) AP215A (cs)
AU (1) AU649453B2 (cs)
BG (1) BG97200A (cs)
CA (1) CA2083714A1 (cs)
CZ (1) CZ279772B6 (cs)
FI (1) FI925766A7 (cs)
HU (1) HUT62881A (cs)
IE (1) IE912025A1 (cs)
IL (1) IL98470A0 (cs)
IS (1) IS3721A7 (cs)
LT (2) LT3952B (cs)
LV (1) LV10953A (cs)
MA (1) MA22199A1 (cs)
NO (1) NO924775D0 (cs)
NZ (1) NZ238546A (cs)
OA (1) OA09682A (cs)
PT (1) PT98035A (cs)
RO (1) RO110493B1 (cs)
SE (1) SE9002206D0 (cs)
TN (1) TNSN91049A1 (cs)
TW (1) TW216418B (cs)
WO (1) WO1991019711A1 (cs)
YU (1) YU104191A (cs)
ZA (2) ZA914296B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
BR0017140A (pt) 2000-02-24 2004-05-25 Kopran Res Lab Ltd Derivados de benzimidazol anti-úlcera estáveis ácidos para administração oral
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
EP2184058B1 (en) 2003-09-26 2012-02-08 ALZA Corporation Drug coating providing high drug loading and methods for providing the same
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
CA2658804A1 (en) 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
WO2008047681A1 (fr) * 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
CN102209529A (zh) 2008-09-09 2011-10-05 阿斯利康(瑞典)有限公司 将药物组合物递送至有需要的患者的方法
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN116675674A (zh) * 2016-09-14 2023-09-01 宇凤·简·曾 作为d-胺基酸氧化酶(daao)抑制剂之新颖经取代苯并咪唑衍生物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (cs) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
HU886738D0 (en) * 1987-10-30 1990-02-28 Haessle Ab Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles
ZA889194B (en) * 1987-12-11 1989-08-30 Byk Gulden Lomberg Chemisch Fa Novel benzimidazole derivatives
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物

Also Published As

Publication number Publication date
NZ238546A (en) 1994-03-25
IE912025A1 (en) 1992-01-01
CA2083714A1 (en) 1991-12-21
AU8009791A (en) 1992-01-07
LT3977B (en) 1996-06-25
AU649453B2 (en) 1994-05-26
HUT62881A (en) 1993-06-28
IS3721A7 (is) 1991-12-21
AP215A (en) 1992-09-02
ZA914297B (en) 1992-03-25
LV10953A (lv) 1995-12-20
BG97200A (bg) 1993-12-24
CZ279772B6 (cs) 1995-06-14
RO110493B1 (ro) 1996-01-30
JPH05507713A (ja) 1993-11-04
TNSN91049A1 (fr) 1992-10-25
CN1058212A (zh) 1992-01-29
LT3952B (en) 1996-05-27
FI925766A0 (fi) 1992-12-18
TW216418B (cs) 1993-11-21
LTIP1713A (en) 1995-08-25
EP0535081A1 (en) 1993-04-07
NO924775L (no) 1992-12-10
CS189491A3 (en) 1992-04-15
YU104191A (sh) 1994-01-20
OA09682A (en) 1993-05-15
FI925766A7 (fi) 1992-12-18
NO924775D0 (no) 1992-12-10
SE9002206D0 (sv) 1990-06-20
MA22199A1 (fr) 1992-04-01
LTIP1712A (en) 1995-08-25
WO1991019711A1 (en) 1991-12-26
ZA914296B (en) 1992-03-25
PT98035A (pt) 1992-03-31
AP9100285A0 (en) 1991-07-31
HU9204033D0 (en) 1993-03-29

Similar Documents

Publication Publication Date Title
ZA914297B (en) Substituted benzimidazoles,process for their preparation and their pharmaceutical use
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
EP0468372A3 (en) Substituted azoles, process for their preparation and their use
IL92798A0 (en) Benzimidazole derivatives,process for their preparation and pharmaceutical compositions containing them
EP0412848A3 (en) Quinoline derivatives, process for their preparation and their use as medicaments
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
LTIP709A (en) Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations
FI930633A7 (fi) Bensimidatsolijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
ZA911538B (en) New benzimidazole derivatives,process for their production and their pharmaceutical use
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
GB9121776D0 (en) Benzimidazole derivatives and process for preparation thereof
ZA884878B (en) Substituted benzimidazoles,a process for the preparation thereof,pharmaceutical formulations containing them,and the use thereof
FI942912A7 (fi) Substituoidut bentsimidatsolit, menetelmä niiden valmistamiseksi sekä niiden käyttö
IL111707A0 (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use
EP0473267A3 (en) Acylaminopyridinecarboxamides, process for their preparation and their use as fungicides
ZA908300B (en) Benzimidazole derivatives,their production and use
EP0459198A3 (en) Thioalkanones, procedure for their preparation and their use
ZA902695B (en) Benzimidazoles,medicaments containing these compounds and processes for their preparation
EP0488009A3 (en) Piperidinoalkyl-benzoxazine-and-thiazine-compounds, processes for their preparation and drugs containing them
GB2234748B (en) Quinoline derivatives, process for their preparation and their use as medicaments
EP0477717A3 (en) New 3-substituted cephalosporins, process for their preparation and their use as medicinal preparations
IL101103A0 (en) Physiologically active kanglemycin c,process for preparing the same and use thereof